Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Bronchopulmonary carcinoids (BPCs) are classified into typical carcinoids (TC) and atypical carcinoids (AC), based on the mitotic count and absence/presence of necrosis on pathology specimens. There are limitations to accurate measurement of these criteria. It important to study other markers like Ki-67, to enhance the diagnostic accuracy of lung carcinoids.

Objective And Methodology: Retrospective analysis of BPCs treated with surgery between 2012-2022, to examine the accuracy of Ki-67 on the diagnostic specimen, concordance of diagnostic and resection specimens, diagnostic accuracy of Positron Emission Tomography (PET) and concordance of clinical and pathological staging.

Results: 205 patients were included in the analysis (final diagnosis TC 180, AC 25). Mean age 60.5 years and 68 % female. Ki-67 (<5% vs. 5-30 %) on diagnostic biopsy, available in 64 % (n = 131) of the cohort, had specificity (diagnose TC correctly) of 89.4 % (95 %CI 80.4 %-94.7 %) and sensitivity (diagnose AC correctly) of 77.8 % (40.2 %-96.1 %). This compared to 97.5 % (90.3 %-99.6 %) and 36.4 % (12.4 %-68.4 %) for mitotic count (<2mitoses/2mm vs. 2-10mitoses/2mm) and 100 % (94.4 %-100 %) and 21.4 % (5.7 %-51.2 %) for necrosis (absence vs. presence). A pre-resection diagnosis of TC (including surgical biopsy) shows better concordance with final diagnosis on resection specimen (94.9 %, 95 %CI 88.7 %-97.9 %, n = 117) as compared to the diagnosis of AC 83.3 % (95 %CI 50.9 %-97.1 %, n = 12). Concordance for AC appears higher with image guided lung biopsy 80 % (95 % CI, 29.9 %-98.9 %) than bronchoscopy 50 % (9.5 %-90.5 %). SUVmax on 18FDG-PET was a modest predictor of BPC sub-type with an AUC of 0.684 (95 % CI: 0.545,0.823). The clinical and pathological staging were concordant in 46 % (85/184) cases. However, 27 % (50/184) were upstaged and 13 % (23/172) found to have occult nodal metastases on pathology review of the surgical specimens.

Conclusion: The diagnosis and sub-typing of BPCs on diagnostic specimens is challenging. Our data suggest Ki-67 could increase diagnostic accuracy, but further research is needed to confirm this.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2025.108493DOI Listing

Publication Analysis

Top Keywords

bronchopulmonary carcinoids
8
carcinoids bpcs
8
diagnostic accuracy
8
pathological radiological
4
radiological variables
4
variables diagnosis
4
diagnosis bronchopulmonary
4
carcinoids
4
bpcs focus
4
focus antigen
4

Similar Publications

Introduction: Among neuroendocrine lung cancers, lung carcinoids (LCs, further divided into typical [TC] and atypical [AC]) are rare, representing only the 2% of all bronchopulmonary malignancies, and lack prognostic classification and stratification.

Methods: We audited 2 international cohorts of patients with a confirmed diagnosis of LC for prognostic analysis. We used data from the Christie Hospital (Manchester, UK, N = 282) and validated our findings using the cohort of Vall d'Hebron Hospital patients (Barcelona, Spain, N = 80).

View Article and Find Full Text PDF

Bronchopulmonary carcinoids are rare neuroendocrine tumors, categorized as either typical (low-grade malignancy) or atypical (intermediate-grade malignancy), with an incidence of approximately 0.5 per 100000 people. One third of patients remain asymptomatic, while others may present with symptoms such as cough, hemoptysis, and recurrent infections, often resulting from bronchial obstruction.

View Article and Find Full Text PDF

Neuroendocrine neoplasms of the lung include neuroendocrine carcinomas and neuroendocrine tumors (NETs). NETs are also known as carcinoid tumors (CaTs), which are categorized as typical carcinoid and atypical carcinoid (AC). Pulmonary CaTs often metastasize to various sites, including regional lymph nodes, lungs, liver, and bone; however, metastasis to the brain is relatively rare.

View Article and Find Full Text PDF

Carcinoid tumors, originating from neuroendocrine cells, are slow-growing tumors that are predominantly found in the gastrointestinal tract and bronchopulmonary system. Surgical resection is the primary treatment for localized tumors. However, the long-term risk of recurrence, including rare cases of metachronous tumors, presents an ongoing clinical challenge.

View Article and Find Full Text PDF

Pathological & radiological variables in the diagnosis of bronchopulmonary carcinoids (BPCs) with a focus on Antigen Kiel 67 (Ki-67) proliferation index.

Lung Cancer

April 2025

Lung Cancer and Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, the United Kingdom of Great Britain and Northern Ireland; Manchester Academic Health Science Centre (MAHSC), Faculty of Biology, Medicine and Health, University of Manchester,

Background: Bronchopulmonary carcinoids (BPCs) are classified into typical carcinoids (TC) and atypical carcinoids (AC), based on the mitotic count and absence/presence of necrosis on pathology specimens. There are limitations to accurate measurement of these criteria. It important to study other markers like Ki-67, to enhance the diagnostic accuracy of lung carcinoids.

View Article and Find Full Text PDF